CurifyLabs Raises $14M Series A to Power the Future of Personalized Medicine

CurifyLabs, a Helsinki-based HealthTech company transforming how personalised medicines are made, today announced the closing of a €12 million ($14

Finland's CurifyLabs has raised a $14m Series A to expand in the US, where pharmacies in 21 states use its 3D printers to make custom medicine doses.

/PRNewswire/ -- CurifyLabs, a health technology company transforming how personalized medicines are made, today announced the closing of a $14 million Series A...

CurifyLabs Raises $14M Series A to Power the Future of Personalized Medicine

Finland's CurifyLabs has raised a $14m Series A to expand in the US, where pharmacies in 21 states use its 3D printers to make custom medicine doses.

Finnish health technology firm CurifyLabs secured $14 mn to expand US operations and advance automated systems for personalized medicine compounding

CurifyLabs secures $14 million Series A funding, expanding U.S. operations and enhancing innovative medication solutions.

" data-large-file="https://3druck.com/wp-content/uploads/2026/07/CurifyLabs-Team-Series-A-1024x683.webp" /> CurifyLabs hat eine Series-A-Finanzierung über 14 Millionen US-Dollar abgeschlossen. Das finnische Healthtech-Unternehmen will mit dem Kapital vor allem sein Geschäft in den USA ausbauen, Lieferketten stabilisieren und die Weiterentwicklung seiner Systeme für personalisierte Arzneimittel beschleunigen. Angeführt wurde die Runde von Sandwater und HealthCap. Beteiligt waren außerdem Tesi, Lifeline Ventures sowie Kunden und Beschäftigte aus den […] Der Beitrag CurifyLabs erhält 14 Millionen Dollar für 3D-gedruckte Arzneimittel erschien zuerst auf 3Druck.com - The Independent AM Magazine.

CurifyLabs has secured 14 million USD in Series A funding to expand its 3D printed personalised medicine technology. The Finnish company's system combines proprietary software, GMP excipient bases and 3D printing to automate compounding of tailored medications for pharmacies in the US and Europe. https://www.tctmagazine.com/curifylabs-secures-14-million-funding-to-raise-the-bar-for-personalised-3d-printed-medicine/ #3Dprint #3Dprinting #Healthcare

CurifyLabs has successfully secured $14 million in Series A funding aimed at enhancing operations for personalized medicine production, driven by advanced technologies.

CurifyLabs has successfully raised $14 million to enhance personalized medicine through innovative technology solutions and expand operations across the U.S.

Investment from Sandwater, HealthCap, and Tesi will enhance supply chain, customer support, and R&D HELSINKI and JACKSONVILLE, Fla., July 6, 2026 /PRNewswire/ -- CurifyLabs, a health technology company transforming how personalized medicines are made, today announced the closing of a $14...

Investment from Sandwater, HealthCap, and Tesi will enhance supply chain, customer support, and R&D HELSINKI and JACKSONVILLE, Fla., July 6, 2026 /PRNewswire/ -- CurifyLabs, a health technology company transforming how personalized medicines are made, today announced the closing of a $14...

CurifyLabs, a Helsinki-based HealthTech company transforming how personalised medicines are made, today announced the closing of a €12 million ($14

CurifyLabs has secured Series A funding to expand its operations in the US, strengthen its supply chain and accelerate development of its platform for automated, personalised medicine manufacturing.

CurifyLabs has secured Series A funding to expand its operations in the US, strengthen its supply chain and accelerate development of its platform for automated, personalised medicine manufacturing.

Score 7/10 · Impatto: Medium · Finestra: 1 week Asset: HealthTech sector, Personalized medicine market, 3D printing industry The expansion signals a shift toward decentralized pharmaceutical manufacturing, potentially impacting long-term valuations in the HealthTech and 3D printing sectors.

The company CurifyLabs , which specializes in personalized pharmaceutical therapies, has introduced an advanced version of its 3D printing system for compounding pharmacies with the PharmaPrinter Aurum. The device is part of the company’s in-house Compounding System Solution and is designed to replace manual steps in non-sterile drug manufacturing with automated processes. The aim is […] The post CurifyLabs unveils new 3D printer for automated pharmaceutical manufacturing appeared first on 3Printr.com.

In veterinary practices, treatment often fails not because of active ingredients, but because of dosage form and dosing. For many indications, there are no ready-made, species-specific strengths. Pharmacies then resort to conversions from human medicines, crush tablets, or manually compound formulations. These workflows are time-consuming and prone to variability—for example due to uneven drug distribution […] The post CurifyLabs Launches CuraBlend Vet: 3D-Printed Veterinary Medicine as a Dosable, Chewable Gel Tablet appeared first on 3Printr.com.